Welcome to our dedicated page for Rocket Doctor AI news (Ticker: AIRDF), a resource for investors and traders seeking the latest updates and insights on Rocket Doctor AI stock.
Rocket Doctor AI Inc. reports developments tied to its physician-led, AI-powered healthcare technology business and its wholly owned Rocket Doctor Inc. digital health platform and marketplace. Company news commonly covers U.S. payer network agreements, state-by-state access expansion, physician services delivered through the platform, and updates to primary care, chronic disease management, preventive care, virtual urgent care, and specialist coordination.
Recurring announcements also address financial results, product and engineering capacity, equity-based compensation, clinical AI initiatives, and the Global Library of Medicine decision support system. The company’s completed acquisition of Alea Health Holdings Ltd. adds conversational AI-powered mental health capabilities to its healthcare technology profile.
Rocket Doctor AI (CSE:AIDR, OTC:AIRDF, Frankfurt:939) granted 47,013 stock options at $0.71 per share, expiring in three years, and 514,801 RSUs with one-to-three-year terms to consultants and employees. These equity awards follow existing compensation plans, include vesting conditions, and carry a four-month-plus-one-day hold period.
The company also extended digital marketing and investor awareness services from 45 Degrees and Investment Publishing until September 30, 2026, with no additional compensation payable for the extended term.
Rocket Doctor AI (OTC:AIRDF) entered a definitive strategic marketing agreement with Rick Ware Racing and FINTEKK AP, effective June 5, 2026, focused on the 2026 NASCAR Cup Series.
The deal creates a national platform across NASCAR, NHRA, AFT and World Supercross, with exposure on NBC, FOX, USA Network, Amazon Prime, TNT Sports and HBO Max, and includes a potential future investment of up to US$5 million to support U.S. expansion beyond the more than 21 million covered lives already reached.
Rocket Doctor AI (OTC:AIRDF) reported Q1 2026 revenue of $737,103, up 5.7% quarter-over-quarter and 39.3% vs Q3 2025, with a 75% gross margin. Net loss was $4.64 million or $0.05 per share and Adjusted EBITDA loss was $2.89 million.
Cash rose to $3.5 million after a $5.2 million LIFE financing and $2.05 million in warrant exercises. U.S. covered lives expanded to about 21 million, U.S. visits grew 283% quarter-over-quarter, Canada visits increased ~25% year-over-year, and the Alea Health acquisition strengthened AI mental health capabilities.
Rocket Doctor AI (OTC:AIRDF) will host a global virtual Company Town Hall on June 3, 2026. The event, co-led by CEO Dr. Essam Hamza and Rocket Doctor founder and CEO Dr. William Cherniak, will cover 2025 milestones, Q1 2026 highlights, and U.S. growth strategy.
Rocket Doctor AI (OTC:AIRDF) entered a one-year investor relations and marketing agreement with North Star Investor Relations, effective May 15, 2026, subject to regulatory approval.
North Star will receive C$10,000 per month, no shares, options, or performance factors, and currently holds no interest in the company.
Rocket Doctor AI (OTC:AIRDF) and the University of Toronto launched a digital health observership program for first-year Physician Assistant students. The first clinic began on April 14, 2026, using Rocket Doctor’s virtual and hybrid platform.
Students rotate across multiple clinics, observing Physician Assistants and, when available, physicians, gaining exposure to diverse providers, workflows, and patient scenarios while learning technology-enabled care models.
Rocket Doctor AI (OTC: AIRDF) reported audited FY2025 results showing annual revenue of $1,739,219, Q4 2025 revenue of $697,340 (31.8% QoQ growth from Q3), and Q4 EPS of ($0.10). Gross margin for Q4 was 84% and Adjusted EBITDA was a $2.1M loss. The company closed key U.S. in-network payer agreements expanding reach to over 21 million covered lives, received >$500k of an NIH SBIR award, completed the Alea Health acquisition, and raised ~$5.2M in January 2026.
Rocket Doctor Inc. (OTC: AIRDF) was selected to join the Canadian Life Sciences Trade Mission to New York and New Jersey, May 11–14, 2026. Founder and CEO Dr. William Cherniak will deliver a featured two-minute pitch at the Canadian Consulate and meet U.S. investors and partners.
The mission offers access to the New York/New Jersey life sciences corridor, outreach to investors and healthcare leaders, and curated meetings including NYCEDC programming and innovation-hub visits.
Rocket Doctor (OTC: AIRDF) expanded its Maryland in-network reach by ~250,000 additional members, bringing total covered lives in the state to ~3.2 million.
Effective April 27, 2026, the recurring 12-month agreement with a major national payer covers Commercial and Medicare Advantage lines, enabling in-network access to primary care, chronic disease management, preventive services and virtual urgent care, subject to plan eligibility and credentialing.
The deal aligns with Maryland’s 2026 AHEAD model and aims to improve access, continuity of physician-led care, and reduce unnecessary emergency department use.
Rocket Doctor AI (OTC:AIRDF) entered a 30-day addendum with 45 Degrees to run a specialized media services campaign focused on ramping up Google Advertising.
Key terms: a one-time payment of USD $17,000 payable on signing, no equity or options, and no performance-based fees; subject to regulatory approval.